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Abstract
The onset of human cytomegalovirus (HCMV) lytic infection is strictly synchronized with the host cell cycle. Infected G0/
G1 cells support viral immediate early (IE) gene expression and proceed to the G1/S boundary where they finally arrest. In
contrast, S/G2 cells can be infected but effectively block IE gene expression and this inhibition is not relieved until host
cells have divided and reentered G1. During latent infection IE gene expression is also inhibited, and for reactivation to
occur this block to IE gene expression must be overcome. It is only poorly understood which viral and/or cellular
activities maintain the block to cell cycle or latency-associated viral IE gene repression and whether the two mechanisms
may be linked. Here, we show that the block to IE gene expression during S and G2 phase can be overcome by both
genotoxic stress and chemical inhibitors of cellular DNA replication, pointing to the involvement of checkpoint-
dependent signaling pathways in controlling IE gene repression. Checkpoint-dependent rescue of IE expression strictly
requires p53 and in the absence of checkpoint activation is mimicked by proteasomal inhibition in a p53 dependent
manner. Requirement for the cyclin dependent kinase (CDK) inhibitor p21 downstream of p53 suggests a pivotal role for
CDKs in controlling IE gene repression in S/G2 and treatment of S/G2 cells with the CDK inhibitor roscovitine alleviates IE
repression independently of p53. Importantly, CDK inhibiton also overcomes the block to IE expression during quiescent
infection of NTera2 (NT2) cells. Thus, a timely block to CDK activity not only secures phase specificity of the cell cycle
dependent HCMV IE gene expression program, but in addition plays a hitherto unrecognized role in preventing the
establishment of a latent-like state.
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Introduction
Human cytomegalovirus (HCMV) is a wide-spread human
pathogen causing serious disease in immunocompromised patients
and neonates[1].Aswith all herpesviruses, HCMV existseither ina
latent, asymptomatic state or undergoes poductive replication
leading to lysis of the host cell. Lytic replication starts with the
onset of viral immediate early (IE) gene expression. IE gene
products, especially the major IE (MIE) proteins IE1 and IE2, have
essential functions in host cell regulation and in activating the
subsequent cascade of viral early and late gene expression [2]. In
latently infected cells, MIE gene transcription is silenced and
consequently viral gene expression is restricted to only very few
genomic loci [3,4,5,6]. Reactivation from latency is achieved by
mechanismsthattriggerdesilencingofthe MIEpromoter/enhancer
[7,8,9]. Thus, control of MIE gene expression is pivotal to the
outcome of infection and, therefore, represents a main focus of
HCMV research. In addition, MIE gene expression as the initial
step in HCMV replication is considered a prime target for antivirals
and an IE2-specific antisense-RNA (fomivirsen) has already proven
to be effective in the local treatment of HCMV retinitis [10].
Interestingly, latent infection is not the only situation where
HCMV replication is blocked at the level of MIE gene
expression. For primary fibroblasts it has been shown that the
cell cycle state at the onset of infection determines whether
viral gene expression is initiated or not. In G0/G1, IE gene
expression starts immediately while in S/G2 phase, transcrip-
tion of IE1 and IE2 is efficiently suppressed [11,12]. However,
infection of S/G2 fibroblasts does not fully prevent but rather
d e l a y st h eo n s e to ft h el y t i cc y c l eu n t i lc e l l sh a v ec o m p l e t e dc e l l
division and reentered the next G1 phase. The physiological
relevance of the cell cycle dependent regulation of HCMV is
not understood. Furthermore, it is unclear what makes S/G2
cells non-permissive for MIE gene expression and whether the
underlying mechanism also plays a role in the establishment of
HCMV latency.
Here we analyzed the molecular determinants of cell cycle
dependent repression of HCMV major IE genes. We found that
inhibition of cyclin dependent kinase activity either by checkpoint
activation or the chemical inhibitor roscovitine was sufficient to
fully restore virus permissiveness in S/G2. Moreover, CDK
inhbition was also successful in antagonizing the silencing of lytic
gene expression during quiescent, latent-like infection of undiffer-
entiated NTera2 (NT2) cells, suggesting a mechanistical link
between cell cycle and latency-associated repression of IE gene
transcription.
PLoS Pathogens | www.plospathogens.org 1 September 2010 | Volume 6 | Issue 9 | e1001096Results
The cell cycle-dependent block to HCMV MIE gene
expression is neither a strain nor a cell type-specific
phenomenon
The block to MIE gene expression in S and G2 phase has been
described using the highly attenuated HCMV laboratory strains
Towne [11,12] and AD169 [13]. We first decided to test whether
cell cycle dependent IE expression also applies to low-passage
strains and clinical isolates, as this would also suggest an in vivo
relevance for HCMV infection. To this end, we infected human
fibroblasts with either high-passage strains AD169, Towne and
Davis, low-passage strain Toledo or clinical isolates Merlin, TB40/
e and VHL/e and analyzed the cells for MIE gene expression and
cell cycle distribution (figure 1A). All strains clearly failed to initiate
IE1 and IE2 expression in cells with an S/G2 DNA content. While
typically more than 60% of infected G1 cells were IE1/IE2-
positive at 3 hpi, only a maximum of 13% S/G2 cells supported
MIE expression. Thus, the cell cycle-dependent block to MIE gene
expression is a genuine feature of HCMV and not a mere
consequence of a reduced virulence attributed to fibroblast
adapted laboratory strains.
In contrast to AD169 and Towne, the TB40/e isolate has
retained the broad spectrum of cell tropism characteristic for
HCMV infections in vivo. This enabled us to test whether the S/
G2-specific block of MIE expression also accounts to cell types
other than fibroblasts. We analyzed primary endothelial cells
(HUVEC), two transformed cell lines of epithelial origin (HeLa,
HEK293) and the glioblastoma cell line U373-MG (figure 1B and
C). All cell types tested were permissive for MIE gene expression in
G1 but not S or G2 and hence behaved like primary fibroblasts in
this respect. Together these results underscore the general
relevance of the cell cycle state for virus-host interaction and in
addition, allow more flexibility in choosing informative cellular
systems for further specific experimental approaches.
Prolonged inhibition of DNA replication makes S/G2 cells
permissive for MIE gene expression
To identify molecular determinants of the cell cycle-dependent
block to HCMV gene expression, we first turned to examine a
possible role of cellular DNA synthesis. The rational being that
DNA synthesis is the hallmark of S phase in its own right and the
observation that the block to IE gene expression was often found
more pronounced in S rather than G2 (see figure 1A). Inhibition of
DNA replication was achieved by aphidicolin or hydroxyurea
treatment. When applying these inibitors together with or a few
hours prior to infection we only saw a slight increase of MIE-
positive cells in S/G2 compared to DMSO-treated control cells
(figure 2) suggesting that ongoing DNA replication is not a cause
per se for the inhibition of viral gene expression. However,
preincubating cells with the inhibitor for 18 h or longer prior to
the 5 h infection period, raised the percentage of MIE-positive
cells in the S/G2 compartment to at least the same high level as in
G1 cells. This indicates that prolonged inhibition of cellular DNA
replication induces secondary events that are able to effectively
overcome the S/G2-specific block to HCMV gene expression.
The DNA damage response relieves the block of MIE
gene expression in S/G2
Chemicals that disrupt replication, such as aphidicolin and
hydroxyurea, are known to elicit an ATR-dependent DNA damage
response [14,15]. Thus, the positive influence of replication blockage
on MIE gene expression in S/G2 could be a consequence of
checkpoint activation rather than the absence of DNA synthesis per
se. To address this point, we directly induced DNA damage and
chosetwo independent ways to do so, namely doxorubicin treatment
and ultraviolet (UV) irradiation. To cover both early and delayed
effects of checkpoint activation on viral gene expression, cells were
infected at different time points after induction of DNA damage
(figure 3A). Cells that were infected immediately after DNA damage
showed the same pattern of cell cycle-dependent MIE gene
expression as untreated cells (figure 3B). In contrast, at 24 h and
especiallyat 48 h after DNA damage manycells with anS/G2DNA
content had become permissive for MIE gene expression. This
finding demonstrates two things. First, induction of the DNA
damage checkpoint is indeed effective in creating a supportive
environment for viral MIE gene expression in S/G2. Second, the
events leading to increased permissiveness are likely to be part of the
long-term and not the fast but transient response to cellular DNA
damage.
Checkpoint-induced rescue of MIE gene expression
allows the HCMV lytic cycle to proceed with normal
kinetics
The non-permissive nature of S/G2cellscauses a long delay in the
HCMV replicative cycle, as viral gene expression cannot be initiated
before cells have divided and reentered G1 [11,12]. To investigate
whether the DNA damage-induced rescue of MIE gene expression is
also sufficient to trigger the consecutive gene expression program of
the normal replicative cycle in S/G2 cells, we compared the kinetics
of MIE, early and late gene expression in untreated and doxorubicin
treated cells (figure 4). Consistent with a previous report [11], after
infection of untreated S phase cells the program of lytic gene
expression lagged at least 24 h behind that of infected G1 cells. In
contrast, doxorubicin treated S phase cells were able to support not
only MIE but also the subsequent steps of the viral gene expression
program without delay. Of note, this also includes the pp28 gene.
The fact that expression of true late genes like pp28 depends on the
onset of viral DNA synthesis indicates that also viral DNA replication
was initiated in S/G2 cells with normal kinetics. Taken together,
these data clearly suggest that with the DNA damage-dependent
release of MIE gene expression the major obstacle to HCMV
replication is removed from S phase cells and infection proceeds with
the normal kinetics known from infected G0/G1 cells.
Author Summary
Cyclin-dependent kinases (CDKs) control the cell division
cycle. Many viruses employ CDK activity to control critical
steps of their own replication cycle and to synchronise
their replication with the cell cycle dependent availability
of vital cellular enzymes and molecular building blocks.
Here we show an unexpected antiviral function of CDK
activity at a very early stage of human cytomegalovirus
(HCMV) infection, the onset of immediate early (IE) gene
expression. HCMV is unique amongst herpesviruses in
being unable to initiate IE gene expression during the S/G2
phase of the cell cycle. CDK inhibition by either DNA
damage-dependent induction of the cellular CDK inhibitor
p21 or by the pharmacological CDK inhibitor roscovitine
overcomes this limitation and makes S/G2 cells fully
permissive for HCMV. Importantly, in undifferentiated
NTera2 (NT2) cells, which normally establish a quiescent,
latent-like HCMV infection, CDK inhibition also relieves the
block of IE gene expression, suggesting a more general
role for CDK activity in the control of this important human
pathogen.
CDK Inhibition Rescues Lytic Gene Expression
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expression in S/G2
The p53 tumor suppressor protein governs the long-term
cellular response to genotoxic stress by inducing a p21-dependent
cell cycle arrest or apoptosis [16]. Since the observed rescue of
viral gene expression in S/G2 cells after DNA damage follows
long-term kinetics, we next asked whether this rescue depends on
p53-dependent signalling. To this end we made use of HEL
fibroblasts with a stable p53 knockdown [17]. Using the same
experimental setup as before, we treated p53 knockdown (p53-
KD) and appropriate control (mock-transduced and GFP-KD)
fibroblasts with aphidicolin or doxorubicin and infected them
immediately (0 h) or 24 h after treatment (figure 5A). Immunoblot
analysis confirmed that p53-KD but not control cells resist the
aphidicolin and doxorubicin-induced upregulation of p53 and p21
(figure 5B). The increase of p53 expression in control cells between
0 and 24 h was accompanied by the expected increase in
permissiveness for MIE gene expression in S/G2 (figure 5C). In
contrast, p53-KD cells failed to upregulate MIE genes in S/G2
cells rather showing the typical G1-restricted pattern of MIE gene
expression and this was regardless of whether infection was
initiated at early or late times after DNA damage or inhibition of
DNA replication. This clearly demonstrates that the rescue of
HCMV gene expression in S/G2 relies on p53-dependent
Figure 1. Block of HCMV major immediate early (MIE) gene expression in S/G2 is neither virus strain nor cell type-dependent. (A)
Asynchronously proliferating HEL fibroblasts were infected with the indicated HCMV strains at high multiplicity of infection (MOI=5). Three hours
post infection (hpi) cells were harvested and analyzed for DNA content and MIE gene expression by flow cytometry. Shown are dot plots where cells
were divided into four subpopulations: upper left quadrant - MIE-positive G1 cells (DNA content =2n), lower left quadrant - MIE-negative G1 cells,
upper right quadrant – MIE-positive S/G2 cells (DNA content .2n), lower right quadrant – MIE-negative S/G2 cells. The relative proportion of each
subpopulation is given in percent of total cells. In addition, the percentage of MIE-positive cells in the G1 compartment (both left quadrants) and the
S/G2 compartment (right quadrants) is given as a separate information. These latter values are framed in the small boxes at the top corners of each
diagram. (B, C) The indicated cell lines were infected with HCMV-AD169 (U373 cells, MOI=5) or HCMV-TB40/e (HEK293, HeLa, HUVEC, MOI=1) and
harvested at 5 hpi. Cell cycle position was determined by propidium iodide staining (B) or EdU labelling (C), IE expression by IE1/IE2-specific antibody.
(B) Flow cytometry data were analyzed as described above. (C) Cells were divided into MIE
+EdU
2 (upper left), MIE
2EdU





+ (lower right) fractions. The proportion of each fraction was indicated in percent of total cell number. The small boxes in the top
corners of the diagrams display the percentage of MIE-positive cells in the EdU
+ fractions (left corner) and the EdU
2 fractions (right corner)
respectively.
doi:10.1371/journal.ppat.1001096.g001
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bicin) or replicative (aphidicolin) stress.
Different to our approach, a study by Fortunato et al. employed
24 h aphidicolin treatment to synchronize cells at the G1/S-
transition before HCMV infection [12]. At the time of infection
they released the cells from the aphidicolin block, enabling cells to
recover and cycle through S/G2/M/G1. As the continuous
presence of the drug is needed to keep the replication checkpoint
and p53-dependent signalling active, it is not contradictory to our
findings that their synchronization protocol had no major effect on
the percentage of MIE-positive cells in S/G2.
P53 is a short-lived protein whose abundance is controlled by
Mdm2-mediated ubiquitination and subsequent degradation by
the 26S proteasome [18]. It has been known for some time that the
block to MIE gene expression in S phase can be overcome by
proteasomal inhibitors [12]. However, the reason for that
remained elusive. Given the above results we rationalized that
with respect to MIE expression in S phase p53 might be the
limiting target of proteasomal inhibition. Like DNA damage
proteasomal inhibition leads to p53 stabilisation and consequently
to checkpoint activation. To directly address this hypothesis, we
infected p53-KD and control fibroblasts in the presence of the
proteasome inhibitor MG132 (figure 6A). As expected, after 8 h of
MG132 treatment both p53 and its target p21 had strongly
accumulated in non-infected and HCMV-infected control cells
and this effect was largely suppressed in p53-KD cells (figure 6B).
The following analysis of cell cycle dependent viral MIE gene
expression revealed that the p53 status was indeed crucial for the
increased permissivenes of S phase cells after proteasome
inhibition. In the presence of p53, MG132 treatment resulted in
a marked increase of MIE-positive S phase cells from 20% to 50%
(figure 6C). In contrast, in p53-negative cells proteasomal
inhibition had no influence on MIE gene expression that even
dropped from 15% to 13% in the S phase compartment. Thus, the
finding that unrelated agents such as aphidicolin, doxorubicin and
MG132 rescue MIE gene expression in S phase fibroblasts is a
consequence of their shared ability to induce the p53 tumor
suppressor protein.
Figure 2. Inhibition of cellular DNA synthesis has no immediate but a delayed effect on the start of MIE gene expression in S/G2. (A)
Experimental setup. Proliferating HEL fibroblasts were treated with aphidicolin (Aph) or hydroxyurea (HU) and infected with HCMV-AD169 at the
indicated times after drug addition (0 h). At 5 hpi cells were harvested and subjected to propidium iodide and IE1/IE2-specific antibody staining,
followed by flow cytometry. (B) Shown are dot plots where the numbers indicate the relative proportion of each quadrant in percent of total cells and
(in the small boxes) the percentage of MIE-positive cells within the G1 and S/G2 fractions only, as described in the legend to figure 1.
doi:10.1371/journal.ppat.1001096.g002
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mediated by p21
One of the main effectors of p53-dependent signalling is the
CDK inhibitor p21 [19]. To directly test if p21 is required for the
p53-dependent release of MIE gene expression in S/G2 we
focussed on the HCT116 cell system where somatic knockouts of
both p53 and p21 are available [20]. Because HCT116 cells are of
epithelial origin and therefore non-permissive for fibroblast
adapted HCMV laboratory strains [21] we used the endothelio-
tropic TB40/e isolate for infection. As before, we applied
doxorubicin to induce via DNA damage the p53-p21 checkpoint
axis and analyzed MIE gene expression after infection at early
(0 h) and late times (24 h) post doxorubicin treatment (figure 7A).
It appeared that untreated HCT116 cells in G1 as well as in S/G2
only weakly support MIE gene expression (see left part of
figure 7B). For wild type (wt) and p532/2 cells, the proportion
of MIE-positive cells was below 2% in all cell cycle phases, only
p212/2 cells appeared to be a slightly more supportive of viral
gene expression with up to 5.4% MIE-positive cells in G1.
However, after exposure to doxorubicin the permissiveness of
HCT116 cells increased remarkably (see right hand panels of
figure 7B). A first very minor increase was already visible at 0 h,
yet proved to be independent of p53 and p21. After 24 h, the
number of permissive wt cells was increased to 35% in G1 and
20% in S/G2. This late effect of doxorubicin treatment was almost
completely prevented in p53 and p21 knockout cells.There,
compared to wt cells, the percentage of MIE-positive cells was 3-
fold (p532/2) and 3.5-fold (p212/2) lower in G1 and even 13-
fold (p532/2) and 6-fold (p212/2) lower in S/G2. First, these
results show that in the case of HCT116 cells, viral gene
expression in G1 seems to be subject to the same repressive
mechanism as in S/G2. Second, in addition to p53 the rescue of
MIE gene expression also and equally depends on p21, suggesting
that p21 represents the critical effector of p53 in this context.
CDK inhibition by roscovitine relieves the block to the
initiation of MIE gene expression during S/G2 in a direct,
p53 independent manner
The best understood checkpoint effector functions of p21 are
the inhibition of DNA replication by PCNA binding and the
inhibition of CDK2 and CDK1 activity [19]. To test whether the
p21-dependent effect on MIE gene expression relies on CDK
inhibition, we infected fibroblasts in the presence of the
pharmacological CDK inhibitor roscovitine (also known as
Figure 3. The long-term cellular response to genotoxic stress makes S/G2 cells permissive for MIE gene expression. (A) Experimental
setup. Proliferating HEL fibroblasts were treated with sublethal doses of doxorubicin or UV-C radiation. At the indicated times after treatment, cells
were infected with HCMV-AD169 and harvested 4 h later. (B) Flow cytometry analysis of DNA content and MIE gene expression, as described in the
legend to figure 1.
doi:10.1371/journal.ppat.1001096.g003
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applied in parallel with viral infection, i. e. left on the cells from the
beginning of infection until cell harvest at 4 hpi (figure 8A). The
effects we observed were clearly dose-dependent. Low doses
(5 mM) of roscovitine resulted in a modest increase from 8% to
18% MIE-positive cells in S/G2 (figure 8B) and at medium
concentrations (15 mM) the number further increased to 34%.
However, at the same time and independent of the cell cycle
position the average MIE expression level per cell dropped
significantly with increasing concentrations of roscovitine such that
high doses (50 mM) finally led to an almost complete loss of MIE
gene expression in all cell cycle phases. Thus, roscovitine exerts
two opposing effects during the first hours of HCMV infection.
The cell cycle independent, negative effect on MIE gene
expression has been described [22] and attributed to inefficient
viral transcription caused by the roscovitine-mediated inhibition of
CDK7 and CDK9 [23,24]. However, more pertinent to the
question examined here and in good agreement with the above
data there is a clear positive effect of roscovitine on MIE gene
expression. In a previous study roscovitine (15 mM) was left on
Figure 4. Infection at late times after genotoxic stress allows the HCMV replicative cycle to proceed in S/G2 cells with similar
kinetics as in normal G1 cells. Proliferating HEL fibroblasts were incubated for 60 min with EdU to label S phase cells. After removal of EdU, cells
were treated with doxorubicin (+doxo) or left untreated. 24 h post doxorubicin treatment, or – in the case of untreated cells – immediately after EdU
labelling, cells were infected with HCMV-AD169. Cells were harvested at the indicated times post infection and analyzed for EdU incorporation and
HCMV MIE (IE1/2), early (gB) and late (pp28) gene expression by flow cytometry. The percentage of cells staining positive for the different viral gene
products was displayed as described in the legend to figure 1C.
doi:10.1371/journal.ppat.1001096.g004
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the percentage of IE-positive cells in S/G2 [12]. In this setting, the
negative influence of CDK inhibition on ongoing viral gene
expression probably outweighed the positive effect on its initation.
In order to better discriminate between the two opposing
activities of CDK inhibition, we next modified our experimental
setup. To this end, we only allowed roscovitine on infected cells for
two hours before harvesting cells at 5 hpi (figure 8C). Thus,
roscovitine should have exerted its positive effect on the initiation
of MIE without negatively affecting further viral MIE protein
accumulation. Indeed, this setting avoided the negative impact of
CDK inhibition resulting in a further doubling of MIE-positive
cells in S/G2 (from 34% to 68%) when increasing the roscovitine
concentration from 15 to 25 mM (figure 8D). This further supports
the view that CDK activity acts as a strong inhibitor of the
initiation of viral MIE gene expression during the onset of lytic
infection. Roscovitine treatment also rescued S/G2 phase-specific
MIE gene expression in U373 and HUVEC cells (figure 8E). Even
at high concentrations of roscovitine (50 mM in the case of U373)
MIE gene expression was not impaired to any extent in these cells
reaching high and comparable levels in the S/G2 and G1 cell
cycle phases.
It has been shown that, in addition to CDK inhibition,
roscovitine treatment can also trigger p53-dependent signalling
[25,26]. Although the observed kinetics made it unlikely that the
effect of roscovitine was mediated via p53 signalling, we aimed at
formally excluding this possibility to further unravel the impor-
tance of a direct inhibitory CDK function on initiation of HCMV
MIE gene expression. To this end we analyzed whether
roscovitine – unlike doxorubicin, aphidicolin or MG132 (see
above) – is still effective in the absence of p53. Using p53 positive
control fibroblasts, the direct comparison to doxorubicin treatment
revealed that short-term treatment with roscovitine was as efficient
in creating a permissive state in S/G2 cells as the long-term
Figure 5. P53 is required for the checkpoint-dependent rescue of MIE gene expression in S/G2. HEL fibroblasts were stably transduced
with lentiviruses expressing p53 or GFP-specific shRNAs. The resulting knock-down (KD) cells and a mock-infected control were treated with
aphidicolin or doxorubicin as indicated. Immediately after treatment (0 h) or 24 h later cells were infected with HCMV-AD169 (A). Cells were
harvested 4 h post infection and analyzed for expression of p53, p21 and GAPDH by immunoblotting (B) and for MIE expression versus DNA content
by flow cytometry (C).
doi:10.1371/journal.ppat.1001096.g005
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doxorubicin was completely abolished in p53-KD cells, the strong
effect of roscovitine proved to be p53 independent (figure 9).
In summary, these data demonstrate that short-term treatment
with roscovitine can overcome the block to HCMV MIE gene
expression in S/G2. This roscovitine-mediated rescue resembles
the p53 and p21 dependent MIE expression after long-term
checkpoint activation but acts downstream from and independent
of p53, directly targeting CDK activity. Thus, CDK activity exerts
a strong negative effect at the initiation state of HCMV lytic
infection.
CDK inhibition prevents silencing of MIE gene expression
in the NT2 latency model
Latent infection arguably represents the most relevant in vivo
situation where MIE gene expression of HCMV is dominantly
repressed. To address the important question as to whether CDK
activity could also contribute to maintain the block to IE
expression in latently infected cells, we made use of the embryonic
carcinoma cell line NT2, a well-accepted in vitro model for HCMV
latency [27]. In undifferentiated, pluripotent NT2 cells MIE gene
expression is blocked and HCMV establishes a quiescent infection.
The block can be relieved by chemical induction of neuronal
differentiation [28,29,30,31]. This resembles the differentiation
state-dependent permissiveness of cells of the myeloid lineage, a
major site of HCMV latency in vivo [32].
To analyze a possible function of CDKs for the permissiveness
of HCMV in NT2 cells, we adjusted the experimental set up to the
slower kinetics of viral gene expression in NT2 cells (figure 10A).
Two positive controls were included in the experiment. Retinoic
acid (RA)-induced differentiation (as indicated by the downregu-
lation of the pluripotency marker Oct4) enabled MIE gene
expression in 70% of all cells (figure 10B). Trichostatin A (TSA)-
mediated inhibition of histone deacetylases led to 21% IE1/2-
positive cells. However, in this case the rescue of MIE gene
expression was differentiation-independent, which is consistent
with previous reports [33,34]. Intriguingly, transient CDK
inhibition also increased the permissiveness of NT2 cells for
MIE gene expression. This was shown for three different CDK
inhibitors. Besides roscovitine we used another 2,6,9-substituted
purine analogue (CVT313) and a structurally unrelated compound
(SU9516). SU9516 proved to be most effective leading to up to
44% IE1/2-positive cells after 24 h of infection compared to only
1.4% in the DMSO-treated control. Of note, this induction was
not a consequence of CDK inhibitor-induced differentiation since
IE-expressing NT2 cells remained undifferentiated by means of
undisturbed Oct3/4 expression. This result suggests that the
inhibitory function of CDKs on HCMV lytic gene expression is
not restricted to the cell cycle but is likely to have broader
relevance for states of inhibited IE expression. In line with this
reasoning, we were able to show that the induction of MIE gene
expression by transient CDK inhibiton can occur in all cell cycle
phases of NT2 cells even though S/G2 cells reacted most sensitive
at low, suboptimal concentrations of inhibitors (figure 10C).
Given the cell cycle-independent nature of MIE induction by
CDK inhibitors, we asked whether the permissiveness of NT2 cells
might correlate with the expression of a constitutively active 38kD-
form of Cyclin A2 that was recently described in mouse bone
marrow and human myeloid precursor cells [35,36]. Indeed this
Figure 6. The positive effect of proteasome inhibition on MIE
gene expression in S/G2 is mediated by p53 stabilization. (A)
Experimental setup. Proliferating HEL fibroblasts and the indicated
knock-down derivatives were first incubated with EdU to label S-phase
cells. After removal of EdU, cells were infected with HCMV-AD169 or left
uninfected. Together with the virus, the proteasome inhibitor MG132
was added to the cells and was not removed before harvest at 8 hpi. A
solvent control (DMSO) was included. (B) Cells were examined for
expression of the indicated proteins by immunoblot analysis. (C) Flow
cytometry analysis of MIE gene expression and EdU incorporation. The
percentage of MIE-positive cells in the EdU-positive and EdU-negative
fractions respectively were displayed as described in the legend to
figure 1C.
doi:10.1371/journal.ppat.1001096.g006
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cells (figure 11A). In addition, the expression of full-length Cyclin
A2 dropped significantly during retinoic acid-induced differenti-
ation. This is consistent with published data [37] and might at least
partially explain the observation that differentiated NT2 cells
express MIE genes in a completely cell cycle-independent manner
(figure 10C).
An already described determinant of MIE expression in NT2
cells is the differentiation-dependent nuclear localization of the
viral tegument protein pp71 [38]. Nuclear localization of pp71
facilitates MIE gene expression by neutralizing the Daxx-mediated
cellular intrinsic immune defense [39]. To address the question as
to whether the rescue of MIE expression by CDK inhibition works
via nuclear translocation of pp71 we compared the subcellular
localization of pp71 under conditions of CDK inhibition and
retinoic acid-induced differentiation (figure 11B). We found that
the cytoplasmic localization of pp71 in untreated cells was not
affected upon CDK inhibition. In contrast, retinoic acid-treated
cells contained a large fraction of nuclear pp71 as expected. This
suggests that CDK inhibition and pp71 nuclear translocation
trigger independent mechanisms to induce MIE gene expression.
Considering that after retinoic acid treatment MIE expression
occurs in a cell cycle independent fashion (figure 10C) and pp71 is
able to enter the nucleus (figure 11B and [38]) it appears that both
mechanisms can respond to differentiation and therefore might act
synergistically.
Discussion
Here we show for the first time that CDK activity negatively
controls the onset of HCMV gene expression. This finding was
unexpected because HCMV, like many other viruses, was
previously shown to be subject of positive regulation by CDKs.
Apparently, the effect of CDK activity on HCMV varies
depending on the phase of infection and the type of CDK
(see figure 12). At a pre-immediate-early stage of infection, an
Figure 7. DNA damage-dependent rescue of MIE gene expression in S/G2 depends on the CDK inhibitor p21. Proliferating HCT116 wild
type (wt), p532/2 and p212/2 cells were treated with doxorubicin and infected thereafter with HCMV-TB40/e at an MOI of 1. Infection was carried
at 0 or 24 h post doxorubicin treatment (A). Cells were harvested at 7 hpi and analyzed for DNA content and MIE gene expression using flow
cytometry (B), as described in the legend to figure 1.
doi:10.1371/journal.ppat.1001096.g007
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PLoS Pathogens | www.plospathogens.org 9 September 2010 | Volume 6 | Issue 9 | e1001096Figure 8. Roscovitine treatment efficiently abrogates the block of MIE gene expression in S/G2. (A) Experimental setup of B. Proliferating
HEL fibroblasts were infected with HCMV-AD169. Roscovitine, at the indicated concentrations, was added to the cells at the time of infection. It was
left on the cells until harvest at 4 hpi. (C) Experimental setup of D. This time, roscovitine treatment was started 30 min before the fibroblasts were
infected with HCMV. Treatment was stopped at 2 hpi and infected cells were maintained for further 3 h in regular growth medium. (B, D) MIE gene
expression and DNA content of roscovitine treated cells were analyzed by flow cytometry. DMSO treated cells were also analyzed to control for
solvent effects. (E, F) Proliferating U373 and HUVEC cells were incubated with EdU for 60 min to label cells undergoing DNA synthesis. After removal
of EdU, cells were infected with HCMV and harvested 5 h later. Where indicated, roscovitine was transiently added to the cells according to the
schedule described in C. After harvest, cells were analyzed for EdU incorporation and IE1/2-expression by flow cytometry, as detailed in the legend to
figure 1.
doi:10.1371/journal.ppat.1001096.g008
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prevents the initiation of IE gene expression at the level of
transcription (this study and our own unpublished data). Once IE
expression has been initiated, CDK activity is required for
accurate processing and accumulation of viral transcripts [22].
This correlates with recruitment of CDK7 and CDK9 to the sites
of viral transcription where they catalyze hyper-phosphorylation of
the RNA polymerase II C-terminal domain [23,24]. At later times
CDK activity is needed for proper expression, modification and
localization of pUL69, pUL83 and other HCMV proteins and for
efficient production of viral progeny [40,41,42]. Both CDK2 [43]
and CDK9 [40] but not CDK1 [44] are likely to contribute to
these late effects. When CDKs are inhibited througout infection,
the net effect is an almost complete suppression of HCMV
replication [43,44]. Accordingly, CDKs have been suggested as
targets for anti-HCMV therapy [45,46]. However, our data raise a
possible caveat about the use of CDK inhibitors as antiviral drugs
because they might favour HCMV induction in non-permissive
cell types and during latent or latent-like infections.
Several lines of evidence argue that the CDK activity leading to
inhibition of MIE gene expression in S/G2 is provided by Cyclin
A2-CDK1/2.First,CDK1 and CDK2 arethe onlyCDKs inhibited
by both p21 (binds CDK1, 2, 4 and 6 [47]) and roscovitine (targets
CDK1, 2, 5, 7 and 9 [48]). Second, Cyclin A2-dependent kinase
activity is induced at the G1/S transition and remains high until
early prometaphase [49], thus constituting the only Cyclin-CDK
activity profile that matches the non-permissive cell cycle window
for HCMV. Third, HCMV induces high levels of Cyclin E and B-
dependent kinase activity but represses Cyclin A2 in an IE2-
dependent manner [11,50,51,52]. This points towards a model
whereby HCMV – as soon as MIE gene expression has started –
evades the inhibitory influence of Cyclin A2-CDK activity. Also in
thecase oflatent-likeinfectionthe CyclinA2-CDKstatusappearsto
perfectly correlate with the ability of cells to support MIE gene
expression.Retinoicacid-induceddifferentiationwhich preventsthe
establishmentofMIEquiescenceinNT2cellsisalsoknown tocause
downregulation of Cyclin A2 (see also figure 11A), induction of the
CDK inhibitor p27 and inhibition of CDK2 activity [37]. Work is
ongoing in our laboratory to determine the role of Cyclin A2-
dependent kinase activity during lytic infection as well in
experimental models of HCMV latency.
To understand the mechanism of CDK dependent inhibition of
HCMV MIE gene expression it will be essential to know the CDK
substrate mediating this control. One possibility is that a viral
regulator of MIE gene expression changes its activity, expression
or localization depending on the CDK status of the host cell.
Examples for such viral sensors of cellular CDK activity are the
bovine papillomavirus (BPV) protein E1 and the apoptin protein
of chicken anemia virus. BPV-E1, an essential factor for the
initiation of viral replication, is inactivated and marked for nuclear
export in S/G2 by Cyclin A2-CDK2-dependent phosphorylation
[53]. In contrast, apoptin, a tumor selective inducer of apoptosis,
requires phosphorylation by Cyclin A2-CDK2 for nuclear
localization and cell death induction [54]. In the case of HCMV,
the CDK substrate needs to be present at pre-IE times of infection,
so the best viral candidate factors would be tegument proteins
which are delivered as part of the HCMV virion to the host cell.
Importantly, a number of tegument proteins have already been
decribed to exert functions prior to MIE gene expression [55] and
therefore represent possible targets for such a claimed CDK-
dependent mechanism. Candidates include pUS24 [56], pUL26
[57,58], pUL28/29 [59], pUL35 [60,61], pUL47 [62], pUL76
Figure 9. The roscovitine-mediated rescue of MIE gene expression in S/G2 cells is p53 independent. The indicated knock-down
fibroblasts were treated with doxorubicin (+ Doxo) and infected by HCMV 24 later. Or cells were treated with 25 mM roscovitine (+ Rosco) and
infected with HCMV shortly after the start of treatment, as detailed in figure 8C. Cells were harvested at 5 hpi and analyzed for MIE expression and
DNA content, as described in the legend to figure 1.
doi:10.1371/journal.ppat.1001096.g009
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PLoS Pathogens | www.plospathogens.org 12 September 2010 | Volume 6 | Issue 9 | e1001096[63]. The differentiation-dependent subcellular localization of
pp71 that regulates its Daxx-neutralizing function in NT2 and
THP-1 cells [38,39] already provides a proof of principle for the
control of HCMV tegument proteins by cellular factors immedi-
ately after infection. Moreover, the example of the herpes simplex
virus protein VP16 demonstrates that the availability of a
tegument protein can be decisive for the cell cycle sensitivity of
herpesviral IE gene expression [64].
Figure 10. CDK inhibition relieves the block of MIE gene expression in undifferentiated NT2 cells. (A) Experimental setup. NT2 cells were
infected with HCMV-TB40/e (MOI=5) in the presence of the cyclin-dependent kinase (CDK) inhibitors roscovitine (Rosco), CVT313, SU9515, the
histone deacetylase inhibitor trichostatine A (TSA) or solvent (DMSO). CDK inhibitors were used at concentrations from 10 to 50 mM (Rosco, CVT313)
and from 2 to 10 mM (SU9516) as indicated. The different compounds were left on the cells for the indicated lengths of time. In addition, NT2 cells
were infected after a 7-day exposure to retinoic acid (RA). All cells were harvested at 24 hpi. (B) Cells were stained for IE1/2 and Oct3/4 expression and
analyzed by flow cytometry. Shown are dot plots where cells were divided into four subpopulations: MIE
2Oct
2 (lower left quadrant), MIE
+Oct
2
(upper left quadrant), MIE
+Oct
+ (upper right quadrant), MIE
2Oct
+ (lower right quadrant). The proportion of each subpopulation is given as percent of
total cells. (C) Cells were stained for IE1/2 expression and DNA content and analyzed by flow cytometry. The depicted cells were divided into the
following subpopulations: MIE
2G1 (lower left quadrant), MIE
+G1 (upper left quadrant), MIE
+S/G2/M (upper right quadrant) and MIE
-S/G2/M (lower
right quadrant) cells. The proportion of each subpopulation is given in percent of total cells.
doi:10.1371/journal.ppat.1001096.g010
Figure 11. Induction of MIE gene expression by CDK inhibition does not require nuclear localization of pp71. (A) Undifferentiated NT2
cells, differentiated NT2 cells (treated with RA for 7 days) and mouse bone marrow (BM) cells were analyzed for Cyclin A2 expression by immunoblot
analysis. GAPDH expression was analyzed to control for equal loading. (B) Undifferentiated and differentiated NT2 cells were infected with HCMV-
TB40/e (MOI=5). Where indicated, SU9516 at 10 mM final concentration was added together with the virus. At 6 hpi cells were analyzed for
subcellular localization of pp71 (green) by immunofluorescence microscopy. Nuclei were stained with DAPI fluorochrome (blue). Non-infected cells
(right panel) were analyzed to control for background staining. Scale bars (red) =10 mm.
doi:10.1371/journal.ppat.1001096.g011
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controlling MIE gene expression? In a simple view, it enables the
virus to synchronize the onset of its lytic cycle with G0/G1 - the
cell cycle phase that is considered to be most supportive for virus
replication. An alternative scenario is that CDK activity is a
downstream constituent of a p53 sensitive switch that can operate
between latent and lytic infection. In this case cell cycle
dependency of HCMV may be an additional by-product. P53 is
a coordinator of cellular responses to different kinds of stress
including inflammatory [65] and oncogenic stress [66]. Given that
HCMV is frequently found reactivated in inflammatory diseases
and cancer [67], the possibility that activated p53 triggers lytic
gene expression via CDK inhibition appears an attractive option.
Materials and Methods
Cells
Human embryonic lung (HEL) fibroblasts (Fi301, obtained from
the Institute of Virology, Charite ´, Berlin, Germany) were
maintained in Eagle’s minimum essential medium (EMEM)
supplemented with Earle’s balanced salt solution, 25 mM HEPES,
1 mM sodium pyruvate, 2 mM L-alanyl-L-glutamine, nonessen-
tial amino acids, 0.75 % (w/v) sodium bicarbonate, 50 mg/ml
gentamicin and 10% fetal bovine serum (FBS). Human umbilical
vein endothelial cells (HUVEC) were obtained from Lonza
(Walkersville, MD, USA) and maintained in EGM medium
(Lonza) following the manufacturer’s instructions. The generation
of stable p53 and GFP knockdown derivatives was described
elsewhere [17]. U373-MG, HEK293 and HeLa cells (all from
ATCC, Manassas, VA, USA) were maintained in Dulbecco’s
modified Eagle medium (DMEM) supplemented with 10% FBS,
2 mM L-alanyl-L-glutamine, 100 U/ml penicillin and 100 mg/ml
streptomycin. The human colon carcinoma cell line HCT116 and
its p532/2 and p212/2 derivatives were obtained from Bert
Vogelstein (Baltimore, MD, USA) and maintained in McCoy’s
5a medium supplemented with 10% FBS, 5 mM glutamine,
100 U/ml penicillin, and 100 mg/ml streptomycin. The human
teratocarcinoma cell line NTERA-2 (NT2) was obtained from
DSMZ (Braunschweig, Germany) and cultivated on gelatin-coated
dishes in DMEM supplemented with 10% FBS, 5% horse serum,
100 units/ml penicillin, and 100 mg/ml streptomycin. Differenti-
ation of NT2 cells was induced with 10 mM retinoic acid (Sigma-
Aldrich, St. Louis, MO, USA) as described elsewhere (Plotkin,
1984). Where indicated, the following reagents were added to the
cell culture medium: aphidicolin (Sigma-Aldrich, final concentra-
tion: 5 mg/ml), hydroxyurea (Sigma-Aldrich, 1 mM), roscovitine
(Millipore-Calbiochem, 5–50 mM), CVT313 (purchased as CDK2
inhibitor III from Millipore-Calbiochem, 10–50 mM), SU9516
(Santa Cruz Biotechnology, Santa Cruz, CA, USA, 2–10 mM),
trichostatin A (Sigma-Aldrich, 100 ng/ml), MG132 (Sigma-
Aldrich, 2.5 mM). To stop treatment, cells were washed several
times with normal growth medium.
Viruses
The HCMV strains AD169, Davis and Towne were purchased
from ATCC (Manassas, VA, USA). Merlin and Toledo strains
were a gift from Gavin Wilkinson (Cardiff, UK). The endothelio-
tropic isolates TB40/e and VHL/e were a gift from Christian
Sinzger (Tu ¨bingen, Germany). All strains were grown on HEL
fibroblasts. Virus titers were determined by IE1/IE2-fluorescence,
essentially as described [68]. Briefly, quiescent HEL fibroblasts
were infected with various dilutions of virus stocks. After 24 h of
incubation, cells were fixed and stained with IE1/IE2-specific
antibody. Subsequently, the number of positive cells was
determined by flow cytometry and used to calculate viral titers.
Unless otherwise stated, a multiplicity of infection (MOI) of 5 IE
protein forming units (IEU) per cell was used for infection
experiments. Where indicated, cells were pulse-labelled (60 min)
with 10 mM 5-ethynyl-2’-desoxyuridine (EdU, Invitrogen, Carls-
bad, CA, USA) before infection to label S phase cells. Non-
incorporated EdU was removed by several washes with normal
growth medium.
Doxorubicin treatment and UV-irradiation
Doxorubicin (Sigma-Aldrich) was added to the cell culture
medium to a final concentration of 1 mM. After two hours, cells
were washed once with phosphate buffered saline (PBS) and fed
with fresh culture medium. UV-irradiation was carried out using
an UV-Stratalinker 2400 (Stratagene) equipped with 254 nm UV-
light bulbs. For the duration of UV-exposure the culture medium
was replaced with PBS (0.04 ml/cm
2) to avoid the generation of
toxic medium-derived photoproducts. A dosage of 10 J/m
2 UV-C
light was applied which leads in the HEL fibroblasts we used to
high levels of p21 induction (data not shown).
Flow cytometry
Cells were harvested by trypsinization, fixed and permeabilized
by incubation in 75% ethanol for at least 12 h at 4uC and stained
with specific antibodies and propidium iodide as described
previously [13]. The following primary antibodies were used:
anti-IE1/IE2 (clone E13, Argene, Verniolle, France), anti-gB (1-
M-12, Santa Cruz), anti-pp28 (CH19, Santa Cruz), Oct3/4 (C-10,
Santa Cruz). An Alexa Fluor 488-conjugated goat anti-mouse IgG
antibody (Invitrogen) was used as secondary reagent. Isotype-
specific antibodies were used for co-staining of IE1/2 (Alexa Fluor
546-conjugated goat anti-mouse IgG11, Invitrogen) and Oct3/4
Figure 12. Sequential regulation of the HCMV replication cycle by different CDKs. After virus entry a cell cycle-regulated CDK is able to
prevent the onset of IE gene expression. Once IE expression has started, CDK7 and 9 become an essential part of the viral transcription machinery. At
early and late times of infection CDKs are needed for proper function and localization of viral substrates.
doi:10.1371/journal.ppat.1001096.g012
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EdU-positive cells were detected using the Click-iT EdU Alexa
Fluor 647 imaging kit (Invitrogen) according to the manufacturer’s
instructions. Cells were analyzed on FACScan or FACSCanto2
flow cytometers (BD Biosciences, San Jose, CA, USA) using
CellQuest and FACSDiva software packages respectively. Cell
doublets and aggregates were gated out of analysis. All
experiments were performed at least thrice and only representative
results were shown.
Immunoblot analysis
Cells were lysed by sonication in 50 mM Tris-Cl (pH 6.8)–2%
sodium dodecyl sulfate–10% glycerol–1 mM dithiothreitol–2
mg/ml aprotinin–10 mg/ml leupeptin–1 mM pepstatin–0.1 mM
Pefabloc. The lysates were clarified by centrifugation at 17,5006g
and protein concentration was determined using the Bio-Rad DC
protein assay (Bio-Rad Laboratories, Hercules, CA, USA).
Lysates were then adjusted to equal protein concentration,
supplemented with 100 mM dithiothreitol and bromophenol
blue, and heated to 95uC for 3–5 min. Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and immunoblotting were
performed accorded to standard procedures. The following
primary antibodies were used: anti-p53 (clone DO-1, Santa
Cruz), anti-p21 (C-19, Santa Cruz), anti-Cyclin A2 (C-19, Santa
Cruz), anti-GAPDH (mAbcam 9484, Abcam, Cambridge, UK).
HRP conjugated goat anti-mouse-IgG and goat anti-rabbit IgG
(both Santa Cruz) served as secondary antibodies.
Immunofluorescence microscopy
NT2 cells were grown on glass coverslips and treated as
described above. After harvest of the coverslips, cells were washed,
fixed, permeabilized and immunostained exactly as described [38].
A mouse monoclonal antibody against pp71 (clone 2H10, kindly
provided by Tom Shenk, Princeton, NJ, USA) and an Alexa
Fluor-488- coupled goat anti-mouse IgG (Invitrogen) were used as
primary and secondary reagents. Nuclei were counterstained by
the use of 49,6-diamidin-2-phenylindol (DAPI). Images were
acquired by an Eclipse A1 laser scanning microscope using NIS-
Elements software (Nikon Instruments, Tokyo, Japan). Equal
microscope settings and exposure times were used to allow direct
comparison between samples.
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